What You Should Know:
- Advarra, a prominent player in regulatory review solutions and clinical research technology has released findings from its 2023 Study Activation Survey. Since 2018, nearly 60% of clinical research sites have experienced an increase in study volume. The survey reveals sites are also managing more sponsor-provided technology, which is now perceived as a higher burden than contracting and budgeting.
- The 2023 Study Activation Survey aimed to capture the perspectives
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Verana Health Partners with Foundation Fighting Blindness to Integrate Genetic Testing Data into Real-world Evidence Research
What You Should Know:
Verana Health® (Verana), a digital health company helping to revolutionize patient care and clinical research by unlocking the potential of real-world data, and the Foundation Fighting Blindness – the world’s leading organization committed to finding treatments and cures for blinding retinal diseases—announce a partnership focused on providing the life sciences community with deeper and broader data to optimize and expedite clinical trials.Under the
Read More
SubjectWell Acquires PatientCentra, Expanding Ability to Recruit for Rare Disease/Oncology Indications
What You Should Know:
- SubjectWell, a patient access marketplace connecting individuals with chronic health conditions to healthcare options, has acquired PatientCentra, a company specializing in global patient recruitment and personalized recruitment journeys. Financial details of the acquisition were not disclosed.
- This strategic acquisition enhances SubjectWell's capacity to serve patient recruitment needs for international clinical studies and further extends its
Read More
M&A: Viome Acquires Naring Health
What You Should Know:
Viome Life Sciences, a longevity company committed to translating scientific advancements into actionable and individualized health solutions, today announced the acquisition of Naring Health, a digital health and wellness company providing access to individualized clinical and molecular data to empower informed decisions.Under Naring Health, Viome will also be acquiring DiscernDX, a company making regular health monitoring, early disease detection, and
Read More
United Therapeutics to Acquire Miromatrix Medical for $91M
What You Should Know:
- United Therapeutics Corporation and Miromatrix Medical Inc. announced today a definitive agreement for United Therapeutics to acquire Miromatrix for $91M.
- The acquisition of Miromatrix will expand United Therapeutics’ existing complementary platform of organ manufacturing programs, which include ex-vivo lung perfusion, xenotransplantation, 3-D bioprinting, and regenerative medicine approaches with the objective of creating an unlimited supply of tolerable,
Read More
3 Ways for Government to Help Spur Biomedical Innovation
In response to the COVID-19 pandemic, the biomedical community took on the task of developing and deploying critical interventions to address an unprecedented public health emergency. In a remarkable display of collective effort, stakeholders from government and industry came together to produce safe and effective mRNA vaccines as well as therapeutics– a groundbreaking achievement reached in record time. As the biomedical community looks to the future, government agencies have a tremendous
Read More
Georgiamune and Verily Partner to Advance Novel Cancer Treatment
What You Should Know:
- Georgiamune, a privately held, clinical stage biotechnology company, and Verily, an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.
- Through this partnership, Verily and Georgimune will focus on identifying the patient population that could potentially benefit the most from Georgiamune’s GIM-122, a first-in-class dual-functioning antibody that has the potential to help patients with
Read More
M&A: PicnicHealth Acquires Rare Disease Platform AllStripes
What You Should Know:
- Patient-centered health data company PicnicHealth today announced it has acquired AllStripes, a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. Financial terms of the transaction are not disclosed.
- Founded in 2017, AllStripes has developed a technology platform that generates research-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers
Read More
Pangea, FibroFighters Partner to Advance Rare Liver Cancer Treatment
What You Should Know:
Pangea Biomed, the startup behind the innovative treatment response predictor, ENLIGHT, today announced its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.Fibrolamellar carcinoma (FLC) is a rare liver cancer that typically presents in young adolescents and young adults at a median age of 22 who have no history of liver disease. There is no clear standard of care for the disease, and in
Read More
Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients
What You Should Know:
Today, Nucleus RadioPharma the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and University of Missouri.With this round of funding,
Read More
